Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)

Listen Now

Topics Covered

• Review of Chronic Lymphocytic Leukemia, in the Context of COVID-19
• Significant Role of Testing in Informing Your Treatment Choices
• First Line Treatment Options
• Treatment of Relapsed and Refractory CLL
• Re-Testing Importance in Determining Treatment for 2nd and 3rd Line Treatments
• Current Perspectives on New and Emerging Treatments of CLL
• Updates on Clinical Trials and Their Significance for CLL
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & Making Your List of Questions
• Practical Support to Cope with CLL
• Questions for Our Panel of Experts

Our Panel of Experts

Jennifer R. Brown, MD, PhD

Professor of Medicine, Harvard Medical School, Director, CLL Center, Dana Farber Cancer Institute

Mazyar Shadman, MD, MPH

Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology Division, University of Washington, Attending Physician, Seattle Cancer Care Alliance

Patricia Koffman

Co-Founder & Communications Director CLL Society Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on April 08, 2021.